Cefpodoxime (200mg)
Destroys the bacterial cell wall, leading to cell lysis (bursting).
Loading...
Loading...
Cefpodoxime 200mg + Ofloxacin 200 mg
A synergistic, broad-spectrum antimicrobial combination. EXLLA-O pairs Cefpodoxime and Ofloxacin to provide maximum coverage against resistant Gram-positive and Gram-negative pathogens, offering a reliable oral alternative to injectable therapy.
A synergistic, broad-spectrum antimicrobial combination. EXLLA-O pairs Cefpodoxime and Ofloxacin to provide maximum coverage against resistant Gram-positive and Gram-negative pathogens, offering a reliable oral alternative to injectable therapy.
Destroys the bacterial cell wall, leading to cell lysis (bursting).
Penetrates the cell to inhibit DNA Gyrase, preventing the bacteria from replicating its genetic material.
This combination is exceptionally effective against Salmonella typhi strains that have become resistant to single-molecule treatments. It ensures faster fever clearance and reduces the risk of carrier status.
By combining two different classes of antibiotics, Exlla-O covers a massive range of pathogens, including those responsible for "Community-Acquired Pneumonia" and "Complicated Urinary Tract Infecti...
The "Double-Hit" Mechanism:
Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.
